International Journal of Health Policy and Management

International Journal of Health Policy and Management

Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries

Document Type : Correspondence

Authors
Alon Rasooly 1
Yancen Pan 2
Zhenqing Tang 3
Jiangjiang He 3
Ruitai Shao 4
Moriah E. Ellen 1
Orly Manor 5
Shanlian Hu 6
Nadav Davidovitch 1
1 School of Public Health, Ben-Gurion University of the Negev, Beer Sheva, Israel
2 Department of Epidemiology, Fielding School of Public Health, University of California – Los Angeles, Los Angeles, CA, USA
3 Shanghai Health Development Research Center, Shanghai, China
4 Department of Chronic Disease & Multimorbidity, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
5 Braun School of Public Health and Community Medicine, Hebrew University, Jerusalem, Israel
6 School of Public Health, Fudan University, Shanghai, China
10.34172/ijhpm.2024.8491
Keywords
Quality
Primary Healthcare
Diabetes
Implementation Science
China
Global Health

Introduction

 

The centrality of high-quality primary care is universally acknowledged as pivotal to the healthcare system’s performance and the well-being of individuals in society.1 As countries strive to strengthen their primary care foundations, developing and applying tools for measuring performance have become crucial, with some implementing strategies like “pay-for-performance.”2 China has profoundly transformed its health system over the past 25 years since its healthcare reform, particularly its focus on strengthening primary care.3 ...(Read more...)

  1. World Health Organization (WHO). Primary Health Care: Closing the Gap between Public Health and Primary Care through Integration. WHO; 2018.
  2. Gupta N, Ayles HM. Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review. Eur J Health Econ. 2019;20(9):1303-1315. doi:1007/s10198-019-01097-4
  3. Yip W, Fu H, Jian W, et al. Universal health coverage in China part 1: progress and gaps. Lancet Public Health. 2023;8(12):e1025-e1034. doi:1016/s2468-2667(23)00254-2
  4. Rasooly A, Pan Y, Tang Z, et al. Quality and performance measurement in primary diabetes care: a qualitative study in urban China. Int J Health Policy Manag. 2022;11(12):3019-3031. doi:34172/ijhpm.2022.6372
  5. Sun M, Rasooly A, Fan X, Jian W. Assessing the quality of primary healthcare for diabetes in China: multivariate analysis using the China Health and Retirement Longitudinal Study (CHARLS) Database. BMJ Open. 2020;10(12):e035192. doi:1136/bmjopen-2019-035192
  6. Matulis JC III, McCoy RG. Quality measurement as a path to high quality care: Comment on "Quality and performance measurement in primary diabetes care: a qualitative study in urban China". Int J Health Policy Manag. 2023;12(1):7884. doi:34172/ijhpm.2023.7884
  7. Neumann A. Stakeholders’ perceived barriers and successes of quality improvement programs for patients with diabetes: Comment on "Quality and performance measurement in primary diabetes care: a qualitative study in urban China". Int J Health Policy Manag. 2023;12(1):7831. doi:34172/ijhpm.2023.7831
  8. Jian W, Li Q, Zhang L. The performance of primary healthcare in China: the need for a systematic design for improvement: Comment on "Quality and performance measurement in primary diabetes care: a qualitative study in urban China". Int J Health Policy Manag. 2023;12(1):7889. doi:34172/ijhpm.2023.7889
  9. Xu J. Rethinking performance measurement of primary care in China: Comment on "Quality and performance measurement in primary diabetes care: a qualitative study in urban China". Int J Health Policy Manag. 2023;12(1):7825. doi:34172/ijhpm.2023.7825
  10. Al-Rubeaan KA, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, Ibrahim HM. A Web-based interactive diabetes registry for health care management and planning in Saudi Arabia. J Med Internet Res. 2013;15(9):e202. doi:2196/jmir.2722
  11. Porath A, Rabinowitz G, Raskin-Segal A, Weitzman R. Quality Clinical Primary Healthcare Indicators in Israel, Public Report 2003-2005. Israel Ministry of Health, Israel National Institute for Health Policy and Health Services Research; 2006.
  12. Svedbo Engström M, Leksell J, Johansson UB, Gudbjörnsdottir S. What is important for you? A qualitative interview study of living with diabetes and experiences of diabetes care to establish a basis for a tailored patient-reported outcome measure for the Swedish National Diabetes Register. BMJ Open. 2016;6(3):e010249. doi:1136/bmjopen-2015-010249
  13. National Health and Family Planning Commission (NHFPC). National Basic Public Health Service Standard. 3rd ed. NHFPC; 2017.
  14. Gabrys L, Schmidt C, Heidemann C, et al. Diabetes surveillance in Germany - background, concept and prospects. J Health Monit. 2017;2(1):83-95. doi:10.17886/rki-gbe-2017-022
  15. World Health Organization (WHO). Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. WHO; 2013.
  16. Teti A, Gabrys L, Ziese T, et al. Proceedings of the international workshop ‘development of a national diabetes surveillance system in Germany – core indicators and conceptual framework’. BMC Proc. 2017;11(3):3. doi:10.1186/s12919-016-0070-5
  17. Waddington H, Sonnenfeld A, Finetti J, Gaarder M, John D, Stevenson J. Citizen engagement in public services in low- and middle-income countries: a mixed-methods systematic review of participation, inclusion, transparency and accountability (PITA) initiatives. Campbell Syst Rev. 2019;15(1-2):e1025. doi:10.1002/cl2.1025
  18. Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med. 2013;33(6):393-400. doi:10.3343/alm.2013.33.6.393
  19. Szabo SM, Osenenko KM, Qatami L, et al. Quality of care for patients with type 2 diabetes mellitus in Dubai: a HEDIS-like assessment. Int J Endocrinol. 2015;2015:413276. doi:10.1155/2015/413276
  20. Khunti K, Gadsby R, Millett C, Majeed A, Davies M. Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med. 2007;24(12):1436-1441. doi:10.1111/j.1464-5491.2007.02276.x
  21. Chandran A, Selva Kumar S, Hairi NN, Low WY, Mustapha FI. Non-communicable disease surveillance in Malaysia: an overview of existing systems and priorities going forward. Front Public Health. 2021;9:698741. doi:10.3389/fpubh.2021.698741
  22. WHO Regional Office for Europe. Registries and Information Systems for Diabetes Care in the WHO European Region: Preliminary Findings for Consultation. WHO Regional Office for Europe; 2021.
  23. Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633-644. doi:10.1056/NEJMoa1800256
  24. Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care. 2014;37(3):867-875. doi:10.2337/dc13-1870
  25. Chang RE, Lin SP, Aron DC. A pay-for-performance program in Taiwan improved care for some diabetes patients, but doctors may have excluded sicker ones. Health Aff (Millwood). 2012;31(1):93-102. doi:10.1377/hlthaff.2010.0402
  26. Glazier RH, Green ME, Frymire E, et al. Do incentive payments reward the wrong providers? A study of primary care reform in Ontario, Canada. Health Aff (Millwood). 2019;38(4):624-632. doi:10.1377/hlthaff.2018.05272
  27. Minchin M, Roland M, Richardson J, Rowark S, Guthrie B. Quality of care in the United Kingdom after removal of financial incentives. N Engl J Med. 2018;379(10):948-957. doi:10.1056/NEJMsa1801495
  28. McCullough JS, Crespin DJ, Abraham JM, Christianson JB, Finch M. Public reporting and the evolution of diabetes quality. Int J Health Econ Manag. 2015;15(1):127-138. doi:10.1007/s10754-015-9167-z
  29. Calderon-Margalit R, Abu-Ahmed W, Ben-Yehuda A, et al. National Program for Quality Indicators in Community Healthcare in Israel. 2018.
  30. Abdel-Rahman N, Calderon-Margalit R, Cohen A, et al. Longitudinal adherence to diabetes quality indicators and cardiac disease: a nationwide population-based historical cohort study of patients with pharmacologically treated diabetes. J Am Heart Assoc. 2022;11(19):e025603. doi:10.1161/jaha.122.025603
  31. Katz A, Chateau D, Enns JE, et al. Association of the social determinants of health with quality of primary care. Ann Fam Med. 2018;16(3):217-224. doi:10.1370/afm.2236
  32. Walker RJ, Smalls BL, Egede LE. Social determinants of health in adults with type 2 diabetes--contribution of mutable and immutable factors. Diabetes Res Clin Pract. 2015;110(2):193-201. doi:10.1016/j.diabres.2015.09.007
  33. Walker RJ, Gebregziabher M, Martin-Harris B, Egede LE. Independent effects of socioeconomic and psychological social determinants of health on self-care and outcomes in type 2 diabetes. Gen Hosp Psychiatry. 2014;36(6):662-668. doi:10.1016/j.genhosppsych.2014.06.011
  34. National Center for Cardiovascular Diseases (NCCD). Annual Report on Cardiovascular Health and Disease in China 2021. NCCD; 2022.
  35. Hippisley-Cox J, O'Hanlon S, Coupland C. Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population-based survey of 53,000 patients in primary care. BMJ. 2004;329(7477):1267-1269. doi:10.1136/bmj.38279.588125.7C
  36. James GD, Baker P, Badrick E, Mathur R, Hull S, Robson J. Ethnic and social disparity in glycaemic control in type 2 diabetes; cohort study in general practice 2004-9. J R Soc Med. 2012;105(7):300-308. doi:10.1258/jrsm.2012.110289
  37. Nagy A, Kovács N, Pálinkás A, et al. Exploring quality of care and social inequalities related to type 2 diabetes in Hungary: nationwide representative survey. Prim Care Diabetes. 2018;12(3):199-211. doi:10.1016/j.pcd.2017.12.004
  38. Cole MB, Kim JH, Levengood TW, Trivedi AN. Association of Medicaid expansion with 5-year changes in hypertension and diabetes outcomes at federally qualified health centers. JAMA Health Forum. 2021;2(9):e212375. doi:10.1001/jamahealthforum.2021.2375
  39. Weinick RM, Hasnain-Wynia R. Quality improvement efforts under health reform: how to ensure that they help reduce disparities--not increase them. Health Aff (Millwood). 2011;30(10):1837-1843. doi:10.1377/hlthaff.2011.0617
  40. Le C, Rong S, Dingyun Y, Wenlong C. Socioeconomic disparities in type 2 diabetes mellitus prevalence and self-management behaviors in rural southwest China. Diabetes Res Clin Pract. 2016;121:9-16. doi:10.1016/j.diabres.2016.07.032
  41. Xu H, Yang H, Wang H, Li X. The association of residence permits on utilization of health care services by migrant workers in China. Int J Environ Res Public Health. 2021;18(18):9623. doi:10.3390/ijerph18189623
  42. Shen J, Xiao Y. Emerging divided cities in China: socioeconomic segregation in Shanghai, 2000-2010. Urban Stud. 2020;57(6):1338-1356. doi:10.1177/0042098019834233
  43. MRDM. ICHOM Global Benchmarking Platform, Powered by MRDM. https://mrdm.nl/en/ichom/. Accessed August 10, 2021.
  44. Nicolucci A, Greenfield S, Mattke S. Selecting indicators for the quality of diabetes care at the health systems level in OECD countries. Int J Qual Health Care. 2006;18 Suppl 1:26-30. doi:10.1093/intqhc/mzl023
International Journal of Health Policy and Management
Volume 13, Issue 1
2024
Pages 1-5

XML
PDF 911.39 K
Supplementary File
(IJHPM does not take responsibility for any information provided in the supplementary files.)
Rasooly-Supple-File-1-IJHPM.pdf

  • Received Date 11 March 2024
  • Revised Date 24 March 2024
  • Accepted Date 25 March 2024
  • First Published Date 02 April 2024
  • Published Date 01 December 2024